Artículos de revistas
Characterisation Of Functional Endothelin Receptors In The Canine Isolated Perfused Spleen
Registro en:
European Journal Of Pharmacology. , v. 282, n. 1-3, p. 57 - 63, 1995.
142999
10.1016/0014-2999(95)00273-N
2-s2.0-0029113299
Autor
Grassi-Kassisse D.M.
Faro R.
Withrington P.G.
Zatz R.
Opgenorth T.J.
Antunes E.
De Nucci G.
Institución
Resumen
The endothelin receptor subtypes involved in the vasoconstriction, capsular smooth muscle contraction, prostaglandin E2 and prostacyclin release induced by endothelin-1 have been investigated in the canine isolated perfused spleen using both the endothelin ETA receptor antagonist FR 139317 and the endothelin ETB receptor agonist IRL 1620. The isolated canine spleen was perfused with warmed (37°C) and oxygenated (95% O2/5% CO2) Krebs solution at constant flow with continuous recording of splenic arterial perfusion pressure and spleen weight. Samples of splenic venous effluent were collected to determine the amounts of prostaglandin E2 and prostacyclin, measured by radioimmunoassay. Endothelin-1 (4-200 pmol) and IRL 1620 (20-1000 pmol) dose-dependently increased splenic arterial perfusion pressure but the former was more potent on a molar basis (the molar dose ratio IRL/endothelin-1 required to increase splenic arterial vascular resistance by 25% was approximately 33). The infusion of the nitric oxide inibitor Nω-nitro-l-arginine methyl ester (10 μM), but not of the enantiomer Nω-nitro-l-arginine methyl ester, significantly potentiated the increase in splenic arterial vascular resistance induced by endothelin-1. The infusion of FR 139317 (1 μM) markedly attenuated the increased splenic arterial perfusion pressure induced by endothelin-1 without affecting that evoked by IRL 1620. At the highest dose (200 pmol), endothelin-1 induced a small but significant capsule contraction as reflected by the reduction in the spleen weight. The infusion of FR 139317 (1 μM) abolished this contractile effect. IRL 1620 (in doses up to 1000 pmol) did not significantly affect the capsule tone. The administration of either endothelin-1 (20-200 pmol) or IRL 1620 (20-1000 pmol) caused the release of 6-oxo-prostaglandin F1α (breakdown product of prostacyclin) and prostaglandin E2 into the splenic venous effluent. The amount of both prostanoids released by endothelin-1 was significantly greater than that induced by IRL 1620. FR 139317 (1 μM) significantly reduced (P < 0.05) the release of both 6-oxo-prostaglandin F1α and prostaglandin E2 by endothelin-1 without affecting that released by IRL 1620. The results demonstrate that the release of prostaglandins and nitric oxide modulates the vasoconstrictor activity of endothelin-1 in the splenic circulation. Furthermore, the vasoconstriction and eicosanoids (prostacyclin and prostaglandin E2) release by endothelin-1 are due to activation of both endothelin ETA and ETB receptors, although the former seems to be the predominant form. The splenic capsule contraction is mediated by activation of endothelin ETA receptors only. © 1995. 282 1-3 57 63 Arai, Hori, Aramori, Ohkubo, Makanishi, Cloning and expression of a cDNA encoding an endothelin receptor (1990) Nature, 348, p. 730 Bakhle, Moncada, De Nucci, Salmon, Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated lungs (1985) Br. J. Pharmacol., 86, p. 55 Boatman, Brody, Analysis of vascular responses in the spleen (1964) Am. J. Physiol., 207, p. 155 Clozel, Gray, Breu, Loffler, Oster-Walder, The endothelin ETB receptor mediates both vasodilatation and vasoconstriction in vivo (1992) Biochem. Biophys. Res. Commun., 186, p. 867 Corder, Lowry, Withrington, Actions of the peptides, neuropeptide Y and peptide YY, on the vascular and capsular smooth muscle of the isolated, blood-perfused spleen of the dog (1987) Br. J. Pharmacol., 90, p. 785 De Nucci, Thomas, D'Orleans-Juste, Antunes, Walder, Warner, Vane, The pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and EDRF (1988) Proc. Natl. Acad. Sci. USA, 85, p. 9797 De Nucci, Gryglewski, Warner, Vane, The receptor-mediated release of EDRF and PGI2 from bovine aortic endothelial cells is coupled (1988) Proc. Natl. Acad. Sci. USA, 85, p. 2334 Gardiner, Kemp, March, Bennett, Davenport, Edvinsson, Effects of an ET1-receptor antagonist FR 139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6–21) in conscious rats (1994) Br. J. Pharmacol., 112, p. 477 Godfraind, Evidence for heterogeneity of endothelin receptor distribution in human coronary artery (1993) Br. J. Pharmacol., 110, p. 1201 Grassi-Kassisse, Antunes, Withrington, De Nucci, Endogenous prostanoids modulate the vasoconstrictor activity of endothelin-1 in the isolated perfused canine spleen (1994) British Journal of Pharmacology, 113, p. 675 Grassi-Kassisse, Antunes, Sancho, Withrington, De Nucci, The effects and molar potency of iloprost, U46619 and sodium nitroprusside on capsular and vascular smooth muscle of the isolated perfused canine spleen (1994) Prostaglandins Leukotrienes Essent. Fatty Acids, 51, p. 431 Hemsen, Larsson, Lundberg, Characteristics of endothelin A and B binding sites and their vascular effects in pig peripheral tissues (1991) Eur. J. Pharmacol. Mol. Pharmacol., 208, p. 313 Herman, Yano, Filep, The in vivo antiaggregatory action of endothelin-1 is not mediated through the endothelin ETA receptor (1993) Eur. J. Pharmacol., 236, p. 143 Hyslop, De Nucci, The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells (1991) Wien. Klin. Wochenschr., 103, p. 422 Jeng, Savage, Soriano, Balwierczak, Different affinities and selectivities of endothelin-1 and endothelin-3 binding to various rat tissues (1990) Biochem. Int., 22, p. 669 King, Pfeffer, Pfeffer, Brenner, Systemic hemodynamic effects of endothelin in rats (1990) Am. J. Physiol., 258, p. H787 Kohan, Padilla, Hughes, Endothelin B receptor mediates ET-1 effects on cAMP and PGE2 accumulation in rat IMCD (1993) Am J Physiol, 265, p. F670 Matsuda, Beppu, Ohmori, Yamada, Miyatake, Involvement of cyclo-oxygenase-generated vasodilating eicosanoid(s) in addition to nitric oxide in endothelin-1-induced endothelium-dependent vasorelaxation in guinea pig aorta (1993) Heart Vessels, 8, p. 121 May, Mathai, McDougall, Whitworth, Cardiovascular effects of long-term endothelin infusion and responses to endothelin during ACTH infusion in conscious sheep (1993) Am. J. Hypertens., 6, p. 837 McMurdo, Lidbury, Thiemermann, Vane, Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor (1993) Br. J. Pharmacol., 109, p. 530 Moreland, McMullen, Delaney, Lee, Hunt, Venous smooth muscle contains vasoconstrictor ETB-like receptors (1992) Biochem. Biophys. Res. Commun., 184, p. 100 Moreland, McMullen, Abboa-Offei, Seymour, Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature (1994) Br. J. Pharmacol., 112, p. 704 Okamura, Matsumoto, Ikemoto, Toda, Mechanisms of the biphasic responses to endothelin-3 in dog coronary arteries (1992) Br. J. Pharmacol., 107, p. 1037 Okumura, Ashizawa, Kobayashi, Arai, Matsuura, Comparison of haemoconcentration induced by big endothelin-1 and endothelin-1 in mice (1993) Br. J. Pharmacol., 110, p. 1395 Rae, Trybulec, De Nucci, Vane, Endothelin-1 releases eicosanoids from the rabbit isolated perfused kidney and spleen (1989) J. Cardiovasc. Pharmacol., 13, p. S89 Sakurai, Yanagisawa, Takuwa, Miyazai, Kimura, Goto, Masaki, Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor (1990) Nature, 348, p. 732 Salmon, A radioimmunoassay for 6-keto-prostaglandin F1α (1978) Prostaglandins, 15, p. 383 Sirois, Filep, Rousseau, Fournier, Plante, Sirois, Endothelin-1 enhances vascular permeability in conscious rats: role of thromboxane A2 (1992) Eur. J. Pharmacol., 214, p. 119 Sogabe, Nirei, Shoubo, Nomoto, Ao, Notsu, Ono, Pharmacological profile of FR 139317, a novel, potent endothelin ETA receptor antagonist (1993) J. Pharmacol. Exp. Ther., 264, p. 1040 Stanimirovic, Bacic, Uematsu, Spatz, Profile of prostaglandins induced by endothelin-1 in human brain capillary endothelium (1993) Neurochem. Int., 23, p. 385 Sumner, Cannon, Mundin, White, Watts, Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction (1992) Br. J. Pharmacol., 107, p. 858 Takai, Umemura, Yamasaki, Watakabe, Fujitani, Oda, Urade, Okada, A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8–21), IRL 1620, for the ETB receptor (1992) Biochem. Biophys. Res. Commun., 184, p. 953 Télémaque, Gratton, Claing, D'Orleans-Juste, Endothelin-1 induces vasoconstrictions and prostacyclin release via activation of endothelin ETA receptors in the perfused rabbit kidney (1993) Eur. J. Pharmacol., 237, p. 275 Valentin, Gardner, Wiedemann, Humphreys, Modulation of endothelin effects on blood pressure and hematocrit by atrial natriuretic peptide (1991) Hypertension, 17, p. 864 Valentin, Gardner, Ribstein, Mimran, Humphreys, Extravascular shift of fluid and albumin induced by endothelin in binephrectomized rats (1991) Arch. Mal. Coeur Vaiss., 84, p. 1159 Warner, Mitchell, De Nucci, Vane, Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of rat and rabbit (1989) J. Cardiovasc. Pharmacol., 13, p. S85 Warner, Allcock, Corder, Vane, Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF (1993) Br. J. Pharmacol., 110, p. 777 Withrington, De Nucci, Vane, Endothelin-1 causes vasoconstriction and vasodilatation in the blood perfused liver of the dog (1989) J. Cardiovasc. Pharmacol., 13, p. S209 Withrington, Ansari, Croxton, De Nucci, Vane, The actions of endothelins-1 and -3 on the vascular and capsular smooth muscle of the isolated blood perfused spleen of the dog (1992) Br. J. Pharmacol., 105, p. 490 Yanagisawa, Kurihara, Kimura, Tomobe, Kobayashi, Mitsui, Yazaki, Masaki, A novel potent vasoconstrictor peptide produced by vascular endothelial cells (1988) Nature, 332, p. 411 Zimmerman, Martinez, Maymind, Barbee, Effect of endothelin on plasma volume and albumin escape (1992) Circ. Res., 70, p. 1027